fda approved glp-1 receptor agonists glp 1 drugs What to Make of the Coverage and Cost Landscape Trends in the Development of
Description
GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection

For patients without diabetes, brand-name Ozempic may never be covered by insurance at any price, making compounded semaglutide from a licensed pharmacy the only affordable pathway to GLP-1 therapy

Can J Diabetes 2018;42:S316

While they aren't for everyone, these medications can offer a boost for those who need more than lifestyle changes alone to reach their glucose control targets
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
